Clinical Trials

NCT05714553 | TERMINATED | PHASE1/PHASE2
19 participants

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-23
Start Date:
2023-03-08
Completion:
2025-05-30
Conditions
  • Renal Cell Carcinoma
  • Advanced Cancer
  • Advanced Solid Tumor
  • Neoplasm Malignant
  • Metastatic Cancer
  • Melanoma
  • Classical Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Urothelial Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Subungual Squamous Cell Carcinoma
  • Oesophageal Carcinoma
  • MSI-H Colorectal Cancer
  • Gastric Cancer
  • Triple Negative Breast Cancer
  • Endometrial Carcinoma
  • Pleural Mesothelioma
Interventions
  • DRUG
NCT05609370 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
113 participants

A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-23
Start Date:
2023-01-29
Completion:
2025-05-23
Conditions
  • Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
Interventions
  • DRUG
NCT05455658 | ACTIVE_NOT_RECRUITING | PHASE2
33 participants

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-23
Start Date:
2022-11-17
Completion:
2026-06-01
Conditions
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
  • Triple-Negative Breast Carcinoma
Interventions
  • BIOLOGICAL
No Results Yet
NCT05180474 | TERMINATED | PHASE1/PHASE2
179 participants

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-23
Start Date:
2021-12-13
Completion:
2026-03-25
Conditions
  • Breast Cancer, Breast Neoplasms
  • Endometrial Cancer, Endometrial Neoplasm
  • Ovarian Cancer, Ovarian Neoplasms
  • Squamous Non Small Cell Lung Cancer (NSCLC-SCC)
Interventions
  • BIOLOGICAL
No Results Yet
NCT05079399 | RECRUITING
192 participants

Biomarker of Diabetic Retinopathy

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-23
Start Date:
2022-01-01
Completion:
2027-06-30
Conditions
  • Diabetic Retinopathy
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page